{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:25Z","timestamp":1792110265015,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsradet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jacc.2024.07.034","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:01:41Z","timestamp":1727103701000},"page":"1328-1338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol"],"prefix":"10.1016","volume":"84","author":[{"given":"Elias","family":"Bj\u00f6rnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Adiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Gummesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Riitta","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-8091","authenticated-orcid":false,"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.07.034_bib1","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.07.034_bib2","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/eurheartj\/ehad337","article-title":"Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study","volume":"44","author":"Bjornson","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.07.034_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.07.034_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MOL.0000000000000905","article-title":"Triglyceride-rich lipoprotein cholesterol and cardiovascular risk","volume":"34","author":"Bilgic","year":"2023","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"10.1016\/j.jacc.2024.07.034_bib5","first-page":"259","article-title":"Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care","volume":"34","author":"Bilgic","year":"2023","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2024.07.034_bib6","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1093\/eurjpc\/zwac219","article-title":"Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis","volume":"29","author":"Helgadottir","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2024.07.034_bib7","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","article-title":"Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans","volume":"37","author":"Bernelot Moens","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2024.07.034_bib8","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-023-06016-0","article-title":"Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study","volume":"66","author":"Wadstrom","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacc.2024.07.034_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.05.010","article-title":"Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality","volume":"379","author":"Doi","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2024.07.034_bib10","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","article-title":"Neutrophil counts and cardiovascular disease","volume":"44","author":"Luo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.07.034_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2024.07.034_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","article-title":"Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease","volume":"140","author":"Welsh","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.07.034_bib13","article-title":"Glycoprotein acetyls: a novel inflammatory biomarker of early cardiovascular risk in the young","volume":"11","author":"Chiesa","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2024.07.034_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100120","article-title":"GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases","volume":"4","author":"Mehta","year":"2020","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2024.07.034_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","article-title":"Mendelian randomization as a tool for cardiovascular research: a review","volume":"9","author":"Levin","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.07.034_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.jacc.2024.07.034_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11883-023-01153-8","article-title":"Do triglyceride-rich lipoproteins equal low-density lipoproteins in risk of ASCVD?","volume":"25","author":"Wadstrom","year":"2023","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2024.07.034_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.07.034_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2024.07.034_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222362","article-title":"Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates","volume":"14","author":"Rees","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2024.07.034_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41467-019-14156-4","article-title":"A\u00a0robust and efficient method for Mendelian randomization with hundreds of genetic variants","volume":"11","author":"Burgess","year":"2020","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.jacc.2024.07.034_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacc.2024.07.034_bib23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.3874","article-title":"Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms","volume":"49","author":"Howson","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2024.07.034_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOL.0000000000000867","article-title":"Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease","volume":"34","author":"Wadstrom","year":"2023","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2024.07.034_bib25","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724080318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724080318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:15:12Z","timestamp":1759349712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724080318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":25,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0735109724080318"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.07.034","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}